Cellular transplantation is emerging as a potential mechanism with which to augment myocyte number in diseased hearts. To date a number of cell types have been shown to successfully engraft into the myocardium, including fetal, neonatal, and embryonic stem cell-derived cardiomyocytes, skeletal myoblasts, and stem cells with apparent cardiomyogenic potential. Here we provide a review of studies wherein myocytes or stem cells with myogenic potential have been transplanted into the heart. In addition, issues pertaining to the tracking and functional consequences of cell transplantation are discussed.
. Introduction
last transplantation literature will provide a useful database against which to compare the efficacy of cardiomyogenic Cell transplantation is emerging as a potential therapy stem cell transplantation. The remainder of the manuscript with which to treat heart failure. Initial efforts in the field provides our view on issues which influence the interpretafocused on the transplantation of cardiomyocytes as well tion of cell transplantation studies, with specific discusas skeletal myoblasts. More recently, stem cells with sions on methodologies for tracking donor (or homing) apparent cardiomyogenic potential have also been transcells, mechanisms by which cell transplantation can enplanted. Positive results from animal studies have promphance cardiac function, and strategies which might be ted several preliminary clinical trials to ascertain the safety useful for increasing the capacity of donor cells to inteof skeletal myoblast (reviewed in other articles in this grate into the host myocardium. Where appropriate, examissue, see also Ref.
[1]) and bone marrow stem cell [2] ples of studies from our laboratory are provided as transplantation into heart failure patients.
illustrations. Although there has been considerable experimentation with cardiomyocyte and skeletal myoblast transplantation, there are comparably fewer studies wherein multipotent 2 . A review of the myocytye and myogenic stem cell stem cells have been transplanted into the heart. Accordtransplantation literature ingly, we have opted to start our review with a summary of the literature describing cardiomyocyte and skeletal myob- Table 1 provides a summary of studies wherein fetal, last transplantation into the heart. We then describe studies neonatal, or adult cardiomyocytes were transplanted into that report transplantation of cardiomyogenic stem cells. It normal or injured hearts. Studies that describe the transis hoped that the cited cardiomyocyte and skeletal myobplantation of cardiomyocyte cell lines are also listed. Studies for each of these categories are listed in 
Donor cell: F, fetal cardiomyocyte; N, neonatal cardiomyocyte; A, adult cardiomyocyte; C, atrial tumor cell line. Species, donor species /host species: M, mouse; R, rat; H, human; D, dog; P, pig; HM, hamster; C, cell line; 8, autologous transplant. Tracking: D, dye; H, histology; I, immunostain; T, transgenic; CH, Y chromosome; G, donor specific gene (mdx; or sry); V, viral transfection; Ca, calcium phosphate transfection; E, electroporation; Li, liposome gene delivery; M, metabolic label. Heart injury: Normal, Cryoinjury, Reperfusion injury, Coronary occlusion, Genetic (i.e., mdx), Chemical, Cardiotoxic agent. the host animals included mice, rats, rabbits, pigs and coronary artery occlusion, reperfusion injury, chemical dogs. A variety of techniques were used to track the fate of cardiotoxicity, or alternatively into hearts with genetic the donor cells. In some studies, the cardiomyocytes were cardiomyopathies. There were no obvious differences in transplanted into hearts subjected to cryoinjury, permanent the capacity of donor cardiomyocyte seeding in the differ-ent injury models. Several studies performed functional chronological order. Autologous, syngeneic, allogenic and analyses on the hearts following cardiomyocyte transxenogenic transplants have been performed. Most of the plantation, while others determined if cell transplantation studies performed transplantation into injured hearts; carresulted in enhanced angiogenesis. It is very striking that diac damage was induced via cryoinjury, permanent corfor each study in which both cardiac function and donor onary artery occlusion, reperfusion injury or chemical cell-induced angiogenesis were scored, there was a posicardiotoxicity. The vast preponderance of studies contive correlate.
cluded that the transplanted skeletal myoblasts differen- Table 2 provides a summary of studies wherein skeletal tiated into skeletal myotubes. In light of this it is extremely myoblasts were transplanted into normal or injured hearts.
interesting that functional improvement was observed in Myoblasts from neonatal and adult animals, as well as many of the studies. from established myoblast cell lines have been studied. Table 3 provides a summary of studies wherein stem Once again the studies for each category are cited in cells with cardiomyogenic potential have been transplanted Cell type: ESC, embryonic stem cell; BMSC, bone marrow stem cell; NSC, neuronal stem cell; EnSC, endothelial stem cell; HpSC, hepatocyte stem cell; CSC, cardiac stem cell; UNK, unknown cell type. Species, donor species /host species: M, mouse; R, rat; H, human; D, dog; P, pig; HM, hamster; C, cell line; 8, autologous transplant. Cell status at transplant: SC, stem cell; CM, cardiomyocyte; Mobile, mobilized cell population. Delivery: CI, cardiac injection; IU, intrauterine injection; IV, venous injection; AI, arterial injection; BMT, bone marrow transplant; SCI, subcutaneous injection; BI, blastocyst injection; HHT, human heart transplant; 2, not applicable. into normal or injured hearts. A number of different stem planted. In other cases, undifferentiated stem cells were cells have been examined, including embryonic stem cells transplanted either directly into the myocardium or alter-(ESC), bone marrow stem cells (BMSC), neuronal stem natively intravenous route. In the latter case, it was cells (NSC), endothelial stem cells (EnSC), hepatic stem assumed that the stem cells were able to 'home' or migrate cells (HpSC), and cardiac stem cells (CSC). In some to the normal and / or injured myocardium prior to differeninstances, differentiation was induced in vitro, and consetiation. Several other studies are listed wherein the stem quently stem cell-derived cardiomyocytes were transcells were delivered into developing embryos (via blas-tocyst injection or in utero transplantation); these studies donor cells has also been employed to track their fate. This are included as they document the cardiomyogenic potypically entails culturing donor cells in the presence of tential of several cell types. A series of studies examining modified nucleotides (as for example, tritiated thymidine or female hearts that were transplanted into male recipients bromodeoxy uridine, see for example Refs. [19, 57] ), that are listed; the presence of cardiomyocytes with Y-chromobecome incorporated into the cells during DNA replicasomes was suggestive of mobilization of an unknown stem tion; the replicated DNA (and consequently the donor cell cell population. Also cited are studies where analogous nuclei) can later be identified in histological sections. This transplantation and mobilization experiments yielded negaapproach also suffers from potential signal dilution if there tive or markedly different results (studies demarked by is significant donor cell proliferation post-transplantation. **).
Intrinsic genetic differences between donor and host cells have also been employed to monitor cell fate following transplantation. For example, anti-dystrophin immune 3 . Characterization of the fate of transplanted cells cytology was used to follow dystrophin-expressing fetal cardiomyocytes or embryonic stem cell-derived carThe ability to monitor the fate of cells following diomyocytes following transplantation into canine and transplantation into normal or injured hearts is critical.
mouse host animals suffering from Duchenne's-like This is particularly important in instances where myogenic muscular dystrophy (the host animals did not express stem cells are transplanted, as the ability to both track the dystrophin, see Refs. [4, 78] ). Other studies have relied on donor cells and determine the subsequent level of differenmonitoring for the presence of Y-chromosomes following tiation is critical. Because we feel that cell tracking and the transplantation of male donor cardiomyocytes into lineage identification is of paramount importance in interfemale recipients, using quantitative PCR amplification of preting the consequence of myocyte and myogenic stem Y-chromosome specific genes to estimate donor cell cell transplantation, a relatively large portion of the review survival. In situ analyses for the presence of nuclei that is devoted to this topic.
contain a Y-chromosome can also be used to track the fate Many studies examining myocyte transfer have relied of donor cells. However, given the dramatic quantitative simply on the presence of histological differences between differences that have been reported when using this hearts receiving cell transplants as compared to on-transapproach to monitor de novo cardiomyogenic events plant controls. Although this type of analysis is useful as a following the transplantation of human female hearts into first approximation of the effect of cellular transplantation, male recipients (Table 3) , it would appear that the assay is particularly in injured hearts, the preferred approach is to somewhat subjective. utilize molecular analyses that are able to distinguish donor Gene transfer provides an alternative and potentially a and host cells. This is readily accomplished using lineagesuperior approach to monitor the fate of myocytes or restricted immune histological analyses in studies wherein myogenic stem cells following transplantation. fate of transplanted myocytes and myogenic stem cells panel A), and is sensitive enough to detect the presence of [30, 31, 89, [108] [109] [110] . An example of a cluster of EGFPa single surviving bi-nucleated cardiomyocyte (Fig. 2 , expressing fetal cardiomyocytes transplanted into a nonpanel B). transgenic adult mouse heart is shown in Fig. 1 expressing a nuclear-localized b-gal reporter. Due to the and / or acquire a highly differentiated phenotype. Donor extensive sample processing, the X-GAL reaction product cell survival can be monitored by cell counts post-transleaches out of the nucleus, and appears as a peri-nuclear plantation. Nuclear localized b-gal reporters (as described electron dense deposit that is sometimes lodged between above) are particularly well suited for this application as the adjacent myofibers. Donor cells can thus be identified relatively thick heart sections (3001 mm) can be processed without the loss of resolution that can occur with immunoand the surviving cell number directly counted using a logical-based analyses. As always, the accuracy of the dissecting microscope. Because of its relatively small size, analyses are directly dependent upon the fidelity of the the entire mouse heart can be rapidly and quantitatively reagents and / or approaches used to document differentiasurveyed with this assay. This approach is robust enough tion. to permit quantitation of relatively large grafts (Fig. 2, Following the fate of myogenic stem cells requires additional considerations. The use of ubiquitous reporter and extravascular smooth muscle [18, 112, [115] [116] [117] nonegenes provides a robust approach to monitor donor cell theless exhibited some functional improvement as comsurvival and / or homing to injured regions of the heart, but pared to hearts which did not receive cells. Furthermore, is dependent upon secondary analyses (as described above) improved function was also observed in several carto monitor the degree, if any, of myogenic differentiation diomyocyte transplantation studies wherein the number of [85, 89, 91, 98, 100] . While the use of lineage-restricted seeded cells as assessed by histochemical analysis was reporter genes provides an unambiguous way to monitor insufficient to impart a direct functional effect [37] . stem cell differentiation into a specific lineage, in the It is relatively straightforward to understand how celabsence of myogenic differentiation additional analyses are lular transplantation can improve cardiac function if a required to confirm the presence of the donor cell [86] . significant number of donor cells directly participate in a Perhaps the ideal situation is combinatorial assays wherein functional syncytium with the host myocardium. However, compatible ubiquitous and lineage-restricted reporters are it is also important to consider potential mechanisms via both employed in the donor cell.
which transplanted donor cells could benefit cardiac function without directly contributing to systolic contraction. For example, an angiogenic response was observed in 4 . Mechanisms by which cellular transplantation can many studies following cell transplantation (Tables 1-3) . impact heart function An increase in vascular supply could result in the sparing of the chronically ischemic, functionally overloaded A number of the studies cited in Tables 1-3 indicate myocardial tissue bordering the infarcted region. This that myocyte or myogenic stem cell transplantation into notion is directly supported by the observation that ininjured hearts resulted in improved cardiac function as travenous injection of human angioblasts into rats with compared to non-transplanted controls. In most instances it myocardial infarcts resulted in enhanced blood vessel was not clear if the effect on cardiac function resulted as a formation with a concomitant salvage of the at risk direct consequence of the transplanted cells participating in myocardial tissue [118] . Sparing of at risk myocardial a functional syncytium with the host myocardium, or tissue, resulting in preserved left ventricular function, is alternatively if the presence of exogenous cells imparted an also observed clinically following coronary artery bypass indirect yet beneficial effect on the heart. This point is grafting / angioplasty [119] . Similarly, clinical interventions underscored by the observation that in some cases injured to enhance vascular supply can promote the recovery of hearts transplanted with cell types that a priori would not hibernating myocardium [120] . An analogous effect from possess the potential to contribute to cardiac work cycles, donor cell-induced angiogenesis could contribute to the as for example skeletal myocytes (Table 2) , fibroblasts impact on cardiac function. [18, 67, 112] , constituents of the vascular system [113, 114] , In addition to enhanced angiogenesis, myocyte or myogenic stem cell transplantation may also alter the remote electrical stimulation (see Ref. [110] for detailed normal sequela of post MI scar formation and, consecharacterization of the system). An example is shown in quently, ventricular remodeling. Indeed, a consistent ob- Fig. 4 . Panel A shows a two-dimensional image from a servation following skeletal myoblast transplantation in a control heart which was perfused with the calcium sensinumber of studies was a pronounced attenuation of post tive dye Rhod-2. The heart was also perfused with MI ventricular dilation (Table 2) . According to LaPlace's cytochalasin D to facilitate excitation-contraction uncouLaw, retention of a more 'normal' pump size and shape pling. The preparation was paced at a remote site, and the should greatly aid cardiac function. Kloner and colleagues fluorescence signal from three cardiomyocytes at a depth have also suggested that by simply thickening the left of approximately 100 mm from the epicardial surface was ventricular wall, cell transplantation can reduce the degree acquired in line scan mode. The position of the line scan is of systolic dyskinesis, which over time could also impart a indicated by the horizontal white line in panel A, and functional effect [37] . Given these collective experimental integrated traces generated from the line scan data are and clinical precedents, it is quite reasonable to conclude shown in panel B. As can be seen, this assay can be used that the improvement in cardiac function observed in some to record cytosolic calcium transients at the single cell of the studies cited above are quite independent of donor level (as approximated by changes in Rhod-2 fluorescence) cell contractile activity.
within intact hearts. A number of experimental read-outs have been emThe second system requirement was the ability to ployed to quantitate the effect of myocyte or myogenic distinguish host cardiomyocytes from the transplanted stem cell transplantation. As indicated above, traditional cells. In a proof of concept study, fetal donor carmorphometric analyses have clearly documented a reducdiomyocytes from EGFP-expressing transgenic mice were tion in the severity of ventricular remodeling post-injury.
transplanted into non-transgenic hosts, and subjected to A number of direct functional analyses have also been
Rhod-2 fluorescence imaging as described above. The employed to monitor the effect of cell transplantation into optical paths of the imaging system were modified such injured hearts (Tables 1-3) . Many of the studies in rodents that Rhod-2 fluorescence (560-650 nm) and EGFP fluorescomprised ex vivo pressure-volume studies of Langencence (500-550 nm) could be sampled simultaneously dorff-perfused heart preparations with inflatable balloons [31, 109] . Using this approach, calcium transients were inserted into the left ventricle. In some cases, improved simultaneously recorded from donor cardiomyocytes (as exercise tolerance was observed in animals that also identified by EGFP fluorescence) and juxtaposed host showed functional improvement with subsequent ex vivo cardiomyocytes (which lacked EGFP fluorescence). The analyses. Closed chest pressure-volumes studies using study demonstrated that donor and host cardiomyocytes are intra-ventricular transducers have also been performed. electrically coupled to one another, strongly supporting the Echocardiographic analyses have been used to monitor notion that transplanted cardiomyocytes can participate in function in both rodents and larger animals following cell a functional syncytium with the host myocardium. This transplantation. Additionally, ultrasonic crystals have been approach may be useful to monitor the capacity of used to monitor regional wall motion across the infarcted myogenic (i.e., skeletal myoblasts) and cardiomyogenic region of the heart of larger animals following cell stem cells to functionally integrate with the host myocartransplantation. Although these studies have documented dium following transplantation, provided that a transgene that global improvement of cardiac function can occur suitable for imaging is utilized. following cell transplantation, in most instances the assays employed were unable to identify the underlying mechanism (that is, distinguishing between direct contraction of 5 . Strategies to enhance cellular transplantation the donor cells versus a beneficial effect imparted upon the surviving host myocardium). Understanding the mechanisQuantitative PCR studies revealed that the prepondertic basis for improved cardiac function is of critical ance of donor cardiomyocytes die following transplantaimportance when attempting to effect modifications aimed tion into the heart, with typically less than 5% of the cells at enhancing the intervention.
successfully seeding the myocardium [38] . Comparable Accordingly, an imaging-based assay was recently deseeding efficiencies have been obtained by morphological veloped with the goal of determining if myocytes or analysis of transplanted tissue [19] , as well as by direct myogenic stem cells can participate in a functional counts of donor cells carrying the nuclear-localized b-gal syncytium with the host myocardium following transreporter described above (Soonpaa, Pasumarthi, Rubart plantation [31, 109, 110] . The system had two major reand Field, unpublished results). Similarly, with two excepquirements. The first was the ability to image some aspect tions, transplantation and / or homing of myogenic adult of cardiac function at the cellular level within an intact stem cells have resulted in at best only modest accumulaheart. This was accomplished by using two-photon laser tion of de novo muscle cells (see Table 3 ). A high rate of scanning microscopy to monitor the changes in fluoresmyogenic differentiation was reported in one study when cence intensity of calcium sensitive dyes in response to 'lin2 / kit1' hematopoietic stem cells were directly in- jected into hearts with coronary artery ligations [89] . In by providing supplementary matrix). In a very clever contrast, preliminary studies using an analogous system variation of this approach, Murry and colleagues subjected failed to identify any cardiomyogenic events [86] . The donor cells to heat shock prior to transplantation in an other exception, as discussed above, was the relatively effort to activate the endogenous protective HSP70 gene high level of cardiomyocyte chimerization in female hearts [35] . Although this intervention resulted in a transient transplanted into male recipients that was observed in one decrease in the level of donor cell apoptosis following of five studies using similar analytical techniques.
transplantation, it was not clear if this translated to a Collectively these data suggest that interventions aimed permanent increase in donor cell seeding. Finally, several at enhancing donor cell survival, homing, and / or poststudies have demonstrated that co-delivery of growth transplantation proliferation may be required to achieve factors and ES cells resulted in enhanced cardiomyogenic high levels of de novo cardiomyocyte seeding. As can be seeding (Table 3) . seen in Tables 1-3 , some efforts to enhance myocyte and
The availability of transgenic mouse models expressing myogenic stem cell seeding have already been initiated.
cardioprotective or cardioproliferative gene products proThese include relatively descriptive efforts wherein the vide a potentially useful experimental system to identify effects of donor cell age as well as the timing of cell pathways with which to enhance myocyte and myogenic transplantation post-injury were determined. Other studies stem cell transplantation. For example, expression of a have attempted to directly enhance cell survival. These number of different transgenes has resulted in a marked include efforts to inhibit apoptosis (by treating cells with reduction in reperfusion injury following transient corapoptosis inhibitors prior to transplantation), to enhance onary artery occlusion [121] . If reperfusion injury is angiogenesis (by the co-delivery of angiogenic factors with responsible for a major component of myocyte death the donor cells), and to enhance retention of donor cells post-transplantation, the use of donor myocytes or (by incorporating them into three dimensional scaffolds or myogenic stem cells from these transgenic mice should markedly enhance de novo cardiomyocyte seeding. Donor a-myosin heavy chain promoter. The transgene also carcells from transgenic mice expressing pro-survival genes ried sequences encoding hygromycin resistance under the should also be more efficient at engraftment [122] . A transcriptional regulation of the PGK promoter (MHCr r number of transgenic mouse models that exhibit enhanced neo / PGK-hygro transgene). Stably transfected, undifcardiomyocyte proliferation have also been described ferentiated ES cells were selected based on hygromycin [123, 124] ; transplantation of myocytes or myogenic stem resistance. Differentiation was then induced, and carcells from these animals should result in enhanced proliferdiomyocytes were selected based on G418 resistance. Low ation of de novo cardiomyocytes with a concomitant rates of ES-derived cardiomyocyte proliferation were increase in graft size.
observed in these cultures, as evidenced by the relatively In a variation of this theme, genetically modified ES small cardiomyocyte colony size and the absence of cells were recently used to identify gene combinations that tritiated thymidine incorporation (Fig. 5 , panels A and C, permitted proliferative expansion of cardiomyocytes folrespectively). lowing myogenic differentiation [125] . The experiment In other cultures, transgenes encoding anti-apoptotic utilized a selection scheme that resulted in the generation activity (specifically, dominant negative p53 and p193 of pure cardiomyocyte cultures [78] . Undifferentiated ES transgenes) as well as pro-proliferative activity (the E1a cells were transfected with a transgene encoding resistance oncoprotein) were co-transfected with the neomycin / hyto neomycin under the regulation of the cardiac specific gromycin selection cassettes. Markedly enhanced car- diomyocyte proliferation was observed in these cultures, as can be transplanted or mobilized at a density sufficient for evidenced by the marked increase in cardiomyocyte colony global functional impact. Certainly, a similar set of consize and very high rates of tritiated thymidine incorporacerns and caveats are relevant for interventions aimed at tion (Fig. 5, panels B and D, respectively) . These studies inducing cell cycle activity in surviving cardiomyocytes demonstrated that combinatorial blockade of p53 and p193 [123] . activity (via the expression of the corresponding dominant With respect to the ultimate clinical utility of myocyte negative transgenes) was able to abrogate cell cycle-inand myogenic stem cell transplantation, it is important to duced apoptosis, thereby resulting in markedly enhanced recognize that we are still very early in the game. The field proliferation of the ES-derived cardiomyocytes. More of cardiomyogenic stem cell mobilization is even newer. importantly, the study demonstrated that cell cycle activity
The fact that the potential utility of stem cell-based can be readily modulated in in vitro generated cartherapies is becoming highly recognized is underscored by diomyocytes. Although it remains to be seen if these the marked increase in the cell transplantation literature manipulations will ultimately translate to enhanced seeding that has occurred over the last 2 years. With more following transplantation of stem cell-derived carindividuals studying the problem, and more importantly diomyocytes, preliminary results obtained with fetal carwith the increase in the intellectual critical mass that will diomyocytes expressing the same transgenes bode exconcomitantly be applied to the system, it is likely that tremely well for this approach. new advances will rapidly be made. With luck, the utility of these interventions for the treatment of heart failure will be validated.
. Conclusions
It is clear from the studies reviewed here that myocytes A cknowledgements and myogenic stem cells can be stably transplanted into the normal or injured heart, and furthermore that this intervenWe thank NHLBI for support. We also thank our many tion can have a positive impact on cardiac function. colleagues working in the field. We apologize in advance Although improved global cardiac function is the goal of for any relevant views / studies which where inadvertently all cell transplantation therapies, it appears that in many not included. cases cited above the mechanistic basis that gives rise to functional improvement is unclear. In this regard the positive correlation between increased angiogenesis and R eferences increased function is quite striking. If the preponderance of effected myocardial function resulting from cellular trans- angiogenesis. Consequently issues pertaining to the accura- tance. Indeed, this issue underlies our group's concerns 
